Protein | Taxonomy | gefitinib (IC50) | staurosporine (IC50) |
Chain A, Glycogen Synthase Kinase-3 Beta | Homo sapiens (human) | | 0.015 |
Chain B, Glycogen Synthase Kinase-3 Beta | Homo sapiens (human) | | 0.015 |
Chain A, Glycogen Synthase Kinase-3 Beta | Homo sapiens (human) | | 0.015 |
Chain A, Tyrosine-protein kinase ZAP-70 | Homo sapiens (human) | | 0.0558 |
Chain A, Tyrosine-protein kinase SYK | Homo sapiens (human) | | 0.012 |
Chain A, Proto-oncogene serine/threonine-protein kinase Pim-1 | Homo sapiens (human) | | 0.01 |
Chain A, Proto-oncogene serine/threonine-protein kinase Pim-1 | Homo sapiens (human) | | 0.01 |
Chain X, Proto-oncogene tyrosine-protein kinase Fyn | Homo sapiens (human) | | 0.0048 |
Chain A, Serine/threonine-protein kinase TAO2 | Rattus norvegicus (Norway rat) | | 3 |
epidermal growth factor receptor isoform a precursor | Homo sapiens (human) | | 0.4467 |
Serine/threonine-protein kinase Sgk1 | Homo sapiens (human) | | 0.01 |
Cell division cycle 7-related protein kinase | Homo sapiens (human) | | 0.0549 |
Serine/threonine-protein kinase PLK4 | Homo sapiens (human) | | 0.0083 |
Serine/threonine-protein kinase 25 | Homo sapiens (human) | | 0.0029 |
Citron Rho-interacting kinase | Homo sapiens (human) | | 0.749 |
Dual specificity mitogen-activated protein kinase kinase 7 | Homo sapiens (human) | | 0.9255 |
Telomerase reverse transcriptase | Homo sapiens (human) | | 6.9517 |
Serine/threonine-protein kinase Chk1 | Homo sapiens (human) | | 0.1772 |
Inhibitor of nuclear factor kappa-B kinase subunit beta | Homo sapiens (human) | | 0.5561 |
Aurora kinase A | Homo sapiens (human) | | 0.0087 |
Cyclin-G-associated kinase | Homo sapiens (human) | | 0.011 |
Serine/threonine-protein kinase DCLK1 | Homo sapiens (human) | | 0.267 |
Inhibitor of nuclear factor kappa-B kinase subunit alpha | Homo sapiens (human) | | 0.1265 |
Muscle, skeletal receptor tyrosine-protein kinase | Homo sapiens (human) | | 0.1161 |
Mitogen-activated protein kinase 13 | Homo sapiens (human) | | 0.4137 |
3-phosphoinositide-dependent protein kinase 1 | Homo sapiens (human) | | 0.0072 |
Death-associated protein kinase 3 | Homo sapiens (human) | | 0.0026 |
Mitogen-activated protein kinase kinase kinase 7 | Homo sapiens (human) | | 0.0565 |
Receptor-interacting serine/threonine-protein kinase 2 | Homo sapiens (human) | | 0.356 |
Dual specificity tyrosine-phosphorylation-regulated kinase 3 | Homo sapiens (human) | | 0.0231 |
NUAK family SNF1-like kinase 1 | Homo sapiens (human) | | 0.003 |
Cyclin-T1 | Homo sapiens (human) | | 0.0118 |
Cyclin-T2 | Homo sapiens (human) | | 0.0038 |
Tyrosine-protein kinase JAK2 | Homo sapiens (human) | | 0.0016 |
Rho-associated protein kinase 2 | Homo sapiens (human) | | 0.0045 |
Serine/threonine-protein kinase ULK1 | Homo sapiens (human) | | 0.0096 |
Serine/threonine-protein kinase/endoribonuclease IRE1 | Homo sapiens (human) | | 0.1246 |
Ribosomal protein S6 kinase alpha-5 | Homo sapiens (human) | | 0.0011 |
Ribosomal protein S6 kinase alpha-4 | Homo sapiens (human) | | 0.0071 |
Serine/threonine-protein kinase 16 | Homo sapiens (human) | | 0.2385 |
Cyclin-K | Homo sapiens (human) | | 0.0948 |
Serine/threonine-protein kinase PAK 3 | Homo sapiens (human) | | 0.0003 |
Serine/threonine-protein kinase 17B | Homo sapiens (human) | | 0.0258 |
Serine/threonine-protein kinase 10 | Homo sapiens (human) | | 0.008 |
Serine/threonine-protein kinase D3 | Homo sapiens (human) | | 0.1446 |
Cyclin-dependent kinase 14 | Homo sapiens (human) | | 0.1145 |
G2/mitotic-specific cyclin-B2 | Homo sapiens (human) | | 0.0107 |
Mitogen-activated protein kinase kinase kinase 6 | Homo sapiens (human) | | 0.2829 |
Mitogen-activated protein kinase kinase kinase kinase 4 | Homo sapiens (human) | | 0.0005 |
Serine/threonine-protein kinase LATS1 | Homo sapiens (human) | | 0.013 |
Serine/threonine-protein kinase PAK 4 | Homo sapiens (human) | | 0.0132 |
Serine/threonine-protein kinase Chk2 | Homo sapiens (human) | | 0.0212 |
G1/S-specific cyclin-E2 | Homo sapiens (human) | | 0.011 |
cAMP-dependent protein kinase catalytic subunit alpha | Bos taurus (cattle) | | 0.0812 |
Tyrosine-protein kinase ABL1 | Homo sapiens (human) | | 0.1233 |
Proto-oncogene tyrosine-protein kinase Src | Gallus gallus (chicken) | | 0.0063 |
Epidermal growth factor receptor | Homo sapiens (human) | | 0.083 |
RAF proto-oncogene serine/threonine-protein kinase | Homo sapiens (human) | | 0.1281 |
Receptor tyrosine-protein kinase erbB-2 | Homo sapiens (human) | | 0.0713 |
High affinity nerve growth factor receptor | Homo sapiens (human) | | 0.2403 |
Protein kinase C gamma type | Homo sapiens (human) | | 0.1167 |
Platelet-derived growth factor receptor beta | Mus musculus (house mouse) | | 0.002 |
Protein kinase C alpha type | Rattus norvegicus (Norway rat) | | 0.2327 |
Protein kinase C beta type | Homo sapiens (human) | | 0.0684 |
Prostaglandin G/H synthase 1 | Ovis aries (sheep) | | 0.056 |
Insulin receptor | Homo sapiens (human) | | 0.0706 |
Tyrosine-protein kinase Lck | Homo sapiens (human) | | 0.1784 |
Tyrosine-protein kinase Fyn | Homo sapiens (human) | | 0.0929 |
Retinoblastoma-associated protein | Homo sapiens (human) | | 0.066 |
Cyclin-dependent kinase 1 | Homo sapiens (human) | | 0.0075 |
Tyrosine-protein kinase Fes/Fps | Homo sapiens (human) | | 0.0039 |
Macrophage colony-stimulating factor 1 receptor | Homo sapiens (human) | | 0.1269 |
Tyrosine-protein kinase Yes | Homo sapiens (human) | | 0.0029 |
Tyrosine-protein kinase Lyn | Homo sapiens (human) | | 0.0012 |
Proto-oncogene tyrosine-protein kinase receptor Ret | Homo sapiens (human) | | 0.0021 |
Insulin-like growth factor 1 receptor | Homo sapiens (human) | | 0.5534 |
Hepatocyte growth factor receptor | Homo sapiens (human) | | 0.1917 |
Tyrosine-protein kinase HCK | Homo sapiens (human) | | 0.0025 |
Proto-oncogene tyrosine-protein kinase ROS | Homo sapiens (human) | | 0.0004 |
Protein kinase C delta type | Rattus norvegicus (Norway rat) | | 0.274 |
Protein kinase C epsilon type | Rattus norvegicus (Norway rat) | | 0.274 |
Protein kinase C zeta type | Rattus norvegicus (Norway rat) | | 0.274 |
Platelet-derived growth factor receptor beta | Homo sapiens (human) | | 0.3707 |
Tyrosine-protein kinase Fgr | Homo sapiens (human) | | 0.0009 |
Cytochrome P450 2D6 | Homo sapiens (human) | | 0.0002 |
Mast/stem cell growth factor receptor Kit | Homo sapiens (human) | | 0.0412 |
Breakpoint cluster region protein | Homo sapiens (human) | | 0.0945 |
Calcium/calmodulin-dependent protein kinase type II subunit alpha | Rattus norvegicus (Norway rat) | | 0.059 |
Serine/threonine-protein kinase pim-1 | Homo sapiens (human) | | 0.0216 |
Fibroblast growth factor receptor 1 | Homo sapiens (human) | | 0.0699 |
Cyclin-dependent kinase 1 | Mus musculus (house mouse) | | 0.008 |
Cyclin-dependent kinase 4 | Homo sapiens (human) | | 0.0429 |
Proto-oncogene tyrosine-protein kinase Src | Homo sapiens (human) | | 0.3642 |
Acyl-CoA desaturase 1 | Mus musculus (house mouse) | | 3.4 |
Insulin receptor-related protein | Homo sapiens (human) | | 0.0113 |
G2/mitotic-specific cyclin-B1 | Homo sapiens (human) | | 0.0088 |
Dipeptidyl peptidase 4 | Rattus norvegicus (Norway rat) | | 0.003 |
5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | | 4 |
Serine/threonine-protein kinase B-raf | Homo sapiens (human) | | 0.0107 |
Insulin receptor | Mus musculus (house mouse) | | 0.2 |
Phosphorylase b kinase gamma catalytic chain, liver/testis isoform | Homo sapiens (human) | | 0.0004 |
Platelet-derived growth factor receptor alpha | Homo sapiens (human) | | 0.0007 |
Tyrosine-protein kinase Fer | Homo sapiens (human) | | 0.0008 |
Protein kinase C alpha type | Homo sapiens (human) | | 0.0655 |
cAMP-dependent protein kinase catalytic subunit alpha | Homo sapiens (human) | | 0.0115 |
Vascular endothelial growth factor receptor 1 | Homo sapiens (human) | | 0.0149 |
Cytochrome P450 11B2, mitochondrial | Homo sapiens (human) | | 0.011 |
Interferon-induced, double-stranded RNA-activated protein kinase | Homo sapiens (human) | | 0.1 |
Amine oxidase [flavin-containing] B | Rattus norvegicus (Norway rat) | | 0.0025 |
Casein kinase II subunit alpha' | Homo sapiens (human) | | 2.0215 |
Cyclin-A2 | Homo sapiens (human) | | 0.009 |
Cannabinoid receptor 1 | Rattus norvegicus (Norway rat) | | 0.01 |
Serine/threonine-protein kinase MAK | Homo sapiens (human) | | 0.0257 |
Ephrin type-A receptor 1 | Homo sapiens (human) | | 0.0947 |
Fibroblast growth factor receptor 2 | Homo sapiens (human) | | 0.0504 |
Receptor tyrosine-protein kinase erbB-3 | Homo sapiens (human) | | 0.0106 |
Fibroblast growth factor receptor 4 | Homo sapiens (human) | | 0.17 |
Fibroblast growth factor receptor 3 | Homo sapiens (human) | | 0.0554 |
cAMP-dependent protein kinase catalytic subunit gamma | Homo sapiens (human) | | 0.0137 |
Cyclin-O | Homo sapiens (human) | | 0.0015 |
cAMP-dependent protein kinase catalytic subunit beta | Homo sapiens (human) | | 0.0148 |
Ribosomal protein S6 kinase beta-1 | Homo sapiens (human) | | 0.0007 |
Tyrosine-protein kinase JAK1 | Homo sapiens (human) | | 0.004 |
Sodium-dependent dopamine transporter | Rattus norvegicus (Norway rat) | | 0.028 |
G1/S-specific cyclin-D1 | Homo sapiens (human) | | 0.0355 |
Protein kinase C eta type | Homo sapiens (human) | | 0.1165 |
Cyclin-C | Homo sapiens (human) | | 0.0105 |
G1/S-specific cyclin-E1 | Homo sapiens (human) | | 0.0108 |
Cyclin-dependent kinase 2 | Homo sapiens (human) | | 0.0073 |
Beta-adrenergic receptor kinase 1 | Homo sapiens (human) | | 1.1595 |
Platelet-derived growth factor receptor alpha | Mus musculus (house mouse) | | 0.002 |
Mitogen-activated protein kinase 3 | Homo sapiens (human) | | 4.6724 |
MAP/microtubule affinity-regulating kinase 3 | Homo sapiens (human) | | 0.0004 |
cAMP-dependent protein kinase catalytic subunit alpha | Rattus norvegicus (Norway rat) | | 0.055 |
Mitogen-activated protein kinase 1 | Homo sapiens (human) | | 2.6853 |
Ephrin type-A receptor 2 | Homo sapiens (human) | | 0.1257 |
Ephrin type-A receptor 3 | Homo sapiens (human) | | 0.0347 |
Ephrin type-A receptor 8 | Homo sapiens (human) | | 0.1061 |
Ephrin type-B receptor 2 | Homo sapiens (human) | | 0.1191 |
Leukocyte tyrosine kinase receptor | Homo sapiens (human) | | 0.0173 |
Non-receptor tyrosine-protein kinase TYK2 | Homo sapiens (human) | | 0.0137 |
G1/S-specific cyclin-D3 | Homo sapiens (human) | | 0.055 |
Tyrosine-protein kinase receptor UFO | Homo sapiens (human) | | 0.0131 |
RAC-alpha serine/threonine-protein kinase | Homo sapiens (human) | | 0.1848 |
RAC-beta serine/threonine-protein kinase | Homo sapiens (human) | | 0.4119 |
G protein-coupled receptor kinase 4 | Homo sapiens (human) | | 0.0914 |
Kinesin-1 heavy chain | Homo sapiens (human) | | 0.0015 |
G protein-coupled receptor kinase 5 | Homo sapiens (human) | | 0.0489 |
Hexokinase-4 | Homo sapiens (human) | | 0.0006 |
Beta-adrenergic receptor kinase 2 | Homo sapiens (human) | | 0.856 |
Vascular endothelial growth factor receptor 3 | Homo sapiens (human) | | 0.0146 |
Vascular endothelial growth factor receptor 2 | Homo sapiens (human) | | 0.1791 |
Dual specificity mitogen-activated protein kinase kinase 2 | Homo sapiens (human) | | 0.026 |
Receptor-type tyrosine-protein kinase FLT3 | Homo sapiens (human) | | 0.0014 |
Bone morphogenetic protein receptor type-1A | Homo sapiens (human) | | 4.288 |
Activin receptor type-1B | Homo sapiens (human) | | 9.118 |
TGF-beta receptor type-1 | Homo sapiens (human) | | 2.2823 |
Serine/threonine-protein kinase receptor R3 | Homo sapiens (human) | | 0.85 |
Tyrosine-protein kinase CSK | Homo sapiens (human) | | 0.2071 |
Protein kinase C iota type | Homo sapiens (human) | | 0.1739 |
Megakaryocyte-associated tyrosine-protein kinase | Homo sapiens (human) | | 0.442 |
Tyrosine-protein kinase Tec | Homo sapiens (human) | | 0.0338 |
Tyrosine-protein kinase TXK | Homo sapiens (human) | | 0.0203 |
Tyrosine-protein kinase ABL2 | Homo sapiens (human) | | 0.0505 |
Tyrosine-protein kinase FRK | Homo sapiens (human) | | 0.0108 |
G protein-coupled receptor kinase 6 | Homo sapiens (human) | | 0.0473 |
Tyrosine-protein kinase ZAP-70 | Homo sapiens (human) | | 0.0175 |
Tyrosine-protein kinase SYK | Homo sapiens (human) | | 0.0057 |
Mitogen-activated protein kinase 8 | Homo sapiens (human) | | 1.1067 |
Mitogen-activated protein kinase 9 | Homo sapiens (human) | | 2.0555 |
Dual specificity mitogen-activated protein kinase kinase 4 | Homo sapiens (human) | | 0.863 |
Phosphorylase b kinase regulatory subunit alpha, liver isoform | Homo sapiens (human) | | 0.0005 |
Phosphorylase b kinase regulatory subunit alpha, skeletal muscle isoform | Homo sapiens (human) | | 0.0005 |
Dual specificity mitogen-activated protein kinase kinase 3 | Homo sapiens (human) | | 0.0099 |
Casein kinase I isoform alpha | Homo sapiens (human) | | 3.412 |
Casein kinase I isoform delta | Homo sapiens (human) | | 1.4 |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | Homo sapiens (human) | | 9 |
MAP kinase-activated protein kinase 2 | Homo sapiens (human) | | 0.735 |
Cyclin-dependent kinase 8 | Homo sapiens (human) | | 0.0105 |
Casein kinase I isoform epsilon | Homo sapiens (human) | | 1.4 |
Dual specificity protein kinase CLK1 | Homo sapiens (human) | | 0.0108 |
Dual specificity protein kinase CLK2 | Homo sapiens (human) | | 0.6508 |
Dual specificity protein kinase CLK3 | Homo sapiens (human) | | 0.92 |
Glycogen synthase kinase-3 alpha | Homo sapiens (human) | | 0.0103 |
Glycogen synthase kinase-3 beta | Homo sapiens (human) | | 0.0435 |
D(1A) dopamine receptor | Sus scrofa (pig) | | 0.001 |
Cyclin-dependent kinase 7 | Homo sapiens (human) | | 0.2793 |
Cyclin-dependent kinase 9 | Homo sapiens (human) | | 0.0474 |
Tyrosine-protein kinase Blk | Homo sapiens (human) | | 0.0011 |
Interleukin-1 receptor-associated kinase 1 | Homo sapiens (human) | | 0.0377 |
Ribosomal protein S6 kinase alpha-3 | Homo sapiens (human) | | 0.0002 |
Cytoplasmic tyrosine-protein kinase BMX | Homo sapiens (human) | | 0.0046 |
cAMP-dependent protein kinase catalytic subunit PRKX | Homo sapiens (human) | | 0.0014 |
Cyclin-H | Homo sapiens (human) | | 0.2793 |
CDK-activating kinase assembly factor MAT1 | Homo sapiens (human) | | 0.1216 |
Serine/threonine-protein kinase Nek2 | Homo sapiens (human) | | 1.7683 |
Serine/threonine-protein kinase Nek4 | Homo sapiens (human) | | 0.0851 |
Tyrosine-protein kinase JAK3 | Homo sapiens (human) | | 0.0084 |
Dual specificity mitogen-activated protein kinase kinase 6 | Homo sapiens (human) | | 0.0036 |
Serine/threonine-protein kinase PLK1 | Homo sapiens (human) | | 0.4397 |
Death-associated protein kinase 1 | Homo sapiens (human) | | 0.0101 |
LIM domain kinase 1 | Homo sapiens (human) | | 0.0026 |
LIM domain kinase 2 | Homo sapiens (human) | | 0.0956 |
Mitogen-activated protein kinase 12 | Homo sapiens (human) | | 0.4512 |
Mitogen-activated protein kinase 10 | Homo sapiens (human) | | 0.0731 |
5'-AMP-activated protein kinase subunit gamma-1 | Homo sapiens (human) | | 1.1354 |
Ephrin type-B receptor 3 | Homo sapiens (human) | | 1.2855 |
Ephrin type-A receptor 5 | Homo sapiens (human) | | 0.0159 |
Ephrin type-B receptor 4 | Homo sapiens (human) | | 0.1869 |
Ephrin type-B receptor 1 | Homo sapiens (human) | | 0.0694 |
Ephrin type-A receptor 4 | Homo sapiens (human) | | 0.0105 |
Serine/threonine-protein kinase SIK1 | Homo sapiens (human) | | 0.0009 |
Calcium-dependent protein kinase 1 | Plasmodium falciparum K1 | | 0.24 |
Protein kinase C gamma type | Rattus norvegicus (Norway rat) | | 0.2168 |
Casein kinase II subunit beta | Homo sapiens (human) | | 3.4 |
Casein kinase II subunit alpha | Homo sapiens (human) | | 3.4723 |
Protein kinase C beta type | Rattus norvegicus (Norway rat) | | 0.2029 |
SRSF protein kinase 2 | Homo sapiens (human) | | 0.206 |
Casein kinase I isoform gamma-2 | Homo sapiens (human) | | 1.9467 |
Cyclin-A1 | Homo sapiens (human) | | 0.0013 |
Mitogen-activated protein kinase kinase kinase 9 | Homo sapiens (human) | | 0.0044 |
MO15-related protein kinase Pfmrk | Plasmodium falciparum (malaria parasite P. falciparum) | | 4 |
Cyclin-dependent kinase 3 | Homo sapiens (human) | | 0.0118 |
Cyclin-dependent kinase 6 | Homo sapiens (human) | | 0.0395 |
Cyclin-dependent-like kinase 5 | Homo sapiens (human) | | 0.0141 |
Cyclin-dependent kinase 16 | Homo sapiens (human) | | 0.0206 |
Cyclin-dependent kinase 17 | Homo sapiens (human) | | 0.0135 |
Glutamate receptor ionotropic, NMDA 2B | Rattus norvegicus (Norway rat) | | 0.048 |
Protein kinase C epsilon type | Homo sapiens (human) | | 0.0767 |
Dual specificity mitogen-activated protein kinase kinase 1 | Homo sapiens (human) | | 0.2314 |
Angiopoietin-1 receptor | Homo sapiens (human) | | 0.0823 |
Mitogen-activated protein kinase kinase kinase 10 | Homo sapiens (human) | | 0.1952 |
Protein kinase C theta type | Homo sapiens (human) | | 0.1168 |
Activin receptor type-1 | Homo sapiens (human) | | 1.1354 |
Macrophage-stimulating protein receptor | Homo sapiens (human) | | 0.2195 |
Focal adhesion kinase 1 | Homo sapiens (human) | | 0.078 |
Protein kinase C zeta type | Homo sapiens (human) | | 0.1722 |
Protein kinase C delta type | Homo sapiens (human) | | 0.1283 |
Tyrosine-protein kinase BTK | Homo sapiens (human) | | 0.0288 |
Aldehyde oxidase | Homo sapiens (human) | | 0.0023 |
Tyrosine-protein kinase receptor TYRO3 | Homo sapiens (human) | | 0.0177 |
Cyclin-dependent kinase 18 | Homo sapiens (human) | | 0.0587 |
Activated CDC42 kinase 1 | Homo sapiens (human) | | 0.0299 |
Epithelial discoidin domain-containing receptor 1 | Homo sapiens (human) | | 0.9655 |
Tyrosine-protein kinase ITK/TSK | Homo sapiens (human) | | 0.0068 |
Myotonin-protein kinase | Homo sapiens (human) | | 0.1735 |
Mitogen-activated protein kinase kinase kinase 12 | Homo sapiens (human) | | 0.0992 |
Tyrosine-protein kinase Mer | Homo sapiens (human) | | 0.0331 |
Serine/threonine-protein kinase 4 | Homo sapiens (human) | | 0.0013 |
Serine/threonine-protein kinase PAK 1 | Homo sapiens (human) | | 0.0004 |
Dual specificity mitogen-activated protein kinase kinase 5 | Homo sapiens (human) | | 0.0252 |
Mitogen-activated protein kinase 7 | Homo sapiens (human) | | 4.0032 |
Serine/threonine-protein kinase PAK 2 | Homo sapiens (human) | | 0.0021 |
Serine/threonine-protein kinase 3 | Homo sapiens (human) | | 0.0034 |
Mitogen-activated protein kinase kinase kinase 1 | Homo sapiens (human) | | 0.438 |
cGMP-dependent protein kinase 2 | Homo sapiens (human) | | 0.0161 |
Rho-associated protein kinase 1 | Homo sapiens (human) | | 0.0038 |
Non-receptor tyrosine-protein kinase TNK1 | Homo sapiens (human) | | 0.0012 |
Calcium/calmodulin-dependent protein kinase type II subunit beta | Homo sapiens (human) | | 0.0018 |
Calcium/calmodulin-dependent protein kinase type II subunit gamma | Homo sapiens (human) | | 0.0026 |
Calcium/calmodulin-dependent protein kinase type II subunit delta | Homo sapiens (human) | | 0.0024 |
Dual specificity tyrosine-phosphorylation-regulated kinase 1A | Homo sapiens (human) | | 0.0095 |
Bone morphogenetic protein receptor type-2 | Homo sapiens (human) | | 1.94 |
Protein-tyrosine kinase 6 | Homo sapiens (human) | | 0.484 |
cGMP-dependent protein kinase 1 | Homo sapiens (human) | | 0.0027 |
Cyclin-dependent kinase 13 | Homo sapiens (human) | | 0.057 |
Calcium/calmodulin-dependent protein kinase type 1 | Homo sapiens (human) | | 0.0032 |
Inhibitor of nuclear factor kappa-B kinase subunit epsilon | Homo sapiens (human) | | 0.0003 |
Protein-tyrosine kinase 2-beta | Homo sapiens (human) | | 0.0095 |
Maternal embryonic leucine zipper kinase | Homo sapiens (human) | | 0.0006 |
Lysine--tRNA ligase | Homo sapiens (human) | | 0.0049 |
Cyclin-dependent kinase 5 activator 1 | Homo sapiens (human) | | 0.0141 |
[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial | Homo sapiens (human) | | 0.0005 |
Serine/threonine-protein kinase D1 | Homo sapiens (human) | | 0.1448 |
Serine/threonine-protein kinase 38 | Homo sapiens (human) | | 0.0037 |
Receptor tyrosine-protein kinase erbB-4 | Homo sapiens (human) | | 0.183 |
Ribosomal protein S6 kinase alpha-2 | Homo sapiens (human) | | 0.0002 |
Ephrin type-A receptor 7 | Homo sapiens (human) | | 0.0477 |
Ribosomal protein S6 kinase alpha-1 | Homo sapiens (human) | | 0.0004 |
Dual specificity testis-specific protein kinase 1 | Homo sapiens (human) | | 0.1995 |
Myosin light chain kinase, smooth muscle | Homo sapiens (human) | | 0.0448 |
TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 | Homo sapiens (human) | | 0.037 |
Mitogen-activated protein kinase 11 | Homo sapiens (human) | | 1 |
Serine/threonine-protein kinase STK11 | Homo sapiens (human) | | 0.0598 |
Rhodopsin kinase GRK1 | Homo sapiens (human) | | 0.068 |
Coiled-coil domain-containing protein 6 | Homo sapiens (human) | | 0.0022 |
NT-3 growth factor receptor | Homo sapiens (human) | | 0.0002 |
Serine/threonine-protein kinase N1 | Homo sapiens (human) | | 0.0025 |
Serine/threonine-protein kinase N2 | Homo sapiens (human) | | 0.0055 |
Mitogen-activated protein kinase 14 | Homo sapiens (human) | | 0.5052 |
Calcium/calmodulin-dependent protein kinase type IV | Homo sapiens (human) | | 0.1475 |
Mitogen-activated protein kinase kinase kinase 11 | Homo sapiens (human) | | 0.016 |
BDNF/NT-3 growth factors receptor | Homo sapiens (human) | | 0.0004 |
MAP kinase-activated protein kinase 3 | Homo sapiens (human) | | 2.775 |
Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform | Homo sapiens (human) | | 0.0017 |
Discoidin domain-containing receptor 2 | Homo sapiens (human) | | 0.0008 |
Thioredoxin reductase 1, cytoplasmic | Homo sapiens (human) | | 0.0432 |
Rho-associated protein kinase 2 | Bos taurus (cattle) | | 0.0417 |
Myosin light chain kinase 3 | Homo sapiens (human) | | 0.1585 |
Serine/threonine-protein kinase SBK1 | Homo sapiens (human) | | 0.1464 |
Mitogen-activated protein kinase kinase kinase 19 | Homo sapiens (human) | | 0.0087 |
Leucine-rich repeat serine/threonine-protein kinase 2 | Homo sapiens (human) | | 0.0077 |
Mitogen-activated protein kinase kinase kinase 21 | Homo sapiens (human) | | 1.1175 |
Serine/threonine-protein kinase MRCK alpha | Homo sapiens (human) | | 0.0032 |
Sigma non-opioid intracellular receptor 1 | Cavia porcellus (domestic guinea pig) | | 0.0067 |
Testis-specific serine/threonine-protein kinase 1 | Mus musculus (house mouse) | | 0.0003 |
Dual specificity tyrosine-phosphorylation-regulated kinase 1A | Rattus norvegicus (Norway rat) | | 0.012 |
Protein kinase C eta type | Rattus norvegicus (Norway rat) | | 0.274 |
Serine/threonine-protein kinase MRCK gamma | Homo sapiens (human) | | 0.0005 |
Calcium/calmodulin-dependent protein kinase type 1B | Homo sapiens (human) | | 0.0044 |
Serine/threonine-protein kinase Nek5 | Homo sapiens (human) | | 0.0864 |
Serine/threonine-protein kinase N3 | Homo sapiens (human) | | 0.0105 |
Serine/threonine-protein kinase ULK3 | Homo sapiens (human) | | 0.0027 |
Kinase suppressor of Ras 2 | Homo sapiens (human) | | 5.4 |
Dual serine/threonine and tyrosine protein kinase | Homo sapiens (human) | | 0.0552 |
Serine/threonine-protein kinase/endoribonuclease IRE2 | Homo sapiens (human) | | 0.0416 |
Serine/threonine-protein kinase MARK2 | Homo sapiens (human) | | 0.0001 |
Serine/threonine-protein kinase TAO1 | Homo sapiens (human) | | 0.0008 |
Serine/threonine-protein kinase Nek8 | Homo sapiens (human) | | 0.0263 |
Serine/threonine-protein kinase tousled-like 2 | Homo sapiens (human) | | 0.0035 |
Serine/threonine-protein kinase 32C | Homo sapiens (human) | | 0.232 |
Serine/threonine-protein kinase pim-3 | Homo sapiens (human) | | 0.0001 |
Myosin light chain kinase family member 4 | Homo sapiens (human) | | 0.0537 |
Homeodomain-interacting protein kinase 1 | Homo sapiens (human) | | 2.639 |
Calcium/calmodulin-dependent protein kinase type 1D | Homo sapiens (human) | | 0.0003 |
Mitogen-activated protein kinase kinase kinase kinase 3 | Homo sapiens (human) | | 0.0001 |
Kinase suppressor of Ras 1 | Homo sapiens (human) | | 6.265 |
Cyclin-dependent kinase-like 3 | Homo sapiens (human) | | 1.1 |
MAP kinase-activated protein kinase 5 | Homo sapiens (human) | | 0.212 |
Serine/threonine-protein kinase BRSK2 | Homo sapiens (human) | | 0.0028 |
Serine/threonine-protein kinase NIM1 | Homo sapiens (human) | | 0.1102 |
Serine/threonine-protein kinase ULK2 | Homo sapiens (human) | | 0.0032 |
Misshapen-like kinase 1 | Homo sapiens (human) | | 0.0004 |
Serine/threonine-protein kinase DCLK2 | Homo sapiens (human) | | 0.089 |
Calcium/calmodulin-dependent protein kinase kinase 1 | Homo sapiens (human) | | 0.0359 |
Casein kinase I isoform alpha-like | Homo sapiens (human) | | 1.84 |
Cyclin-Y | Homo sapiens (human) | | 0.0518 |
Homeodomain-interacting protein kinase 4 | Homo sapiens (human) | | 0.226 |
Myosin-IIIa | Homo sapiens (human) | | 0.0425 |
Serine/threonine-protein kinase Nek11 | Homo sapiens (human) | | 0.521 |
Protein odd-skipped-related 1 | Homo sapiens (human) | | 0.0402 |
Mitogen-activated protein kinase 15 | Homo sapiens (human) | | 0.0081 |
Serine/threonine-protein kinase Nek9 | Homo sapiens (human) | | 0.101 |
Serine/threonine-protein kinase BRSK1 | Homo sapiens (human) | | 0.0007 |
Serine/threonine-protein kinase haspin | Homo sapiens (human) | | 0.0422 |
Rhodopsin kinase GRK7 | Homo sapiens (human) | | 0.0053 |
G2/mitotic-specific cyclin-B3 | Homo sapiens (human) | | 0.0107 |
Myosin-IIIb | Homo sapiens (human) | | 0.0058 |
Dual specificity tyrosine-phosphorylation-regulated kinase 2 | Homo sapiens (human) | | 0.18 |
Phosphorylase b kinase regulatory subunit beta | Homo sapiens (human) | | 0.0005 |
Serine/threonine-protein kinase Sgk3 | Homo sapiens (human) | | 0.073 |
Aurora kinase B | Homo sapiens (human) | | 0.007 |
Lymphokine-activated killer T-cell-originated protein kinase | Homo sapiens (human) | | 0.0691 |
MAP/microtubule affinity-regulating kinase 4 | Homo sapiens (human) | | 0.0001 |
Calcium/calmodulin-dependent protein kinase type 1G | Homo sapiens (human) | | 0.0047 |
Testis-specific serine/threonine-protein kinase 2 | Homo sapiens (human) | | 0.0038 |
Testis-specific serine/threonine-protein kinase 3 | Homo sapiens (human) | | 0.0051 |
Serine/threonine-protein kinase Nek1 | Homo sapiens (human) | | 0.0122 |
PAS domain-containing serine/threonine-protein kinase | Homo sapiens (human) | | 0.0107 |
Calcium/calmodulin-dependent protein kinase kinase 2 | Homo sapiens (human) | | 0.0246 |
SRSF protein kinase 1 | Homo sapiens (human) | | 0.0337 |
Mitogen-activated protein kinase kinase kinase 14 | Homo sapiens (human) | | 2.3 |
Mitogen-activated protein kinase kinase kinase 5 | Homo sapiens (human) | | 0.215 |
Mitogen-activated protein kinase kinase kinase 3 | Homo sapiens (human) | | 0.0092 |
MAP kinase-interacting serine/threonine-protein kinase 1 | Homo sapiens (human) | | 0.0531 |
Testis-specific serine/threonine-protein kinase 6 | Homo sapiens (human) | | 0.1525 |
Serine/threonine-protein kinase 33 | Homo sapiens (human) | | 0.0374 |
Serine/threonine-protein kinase D2 | Homo sapiens (human) | | 0.0014 |
NUAK family SNF1-like kinase 2 | Homo sapiens (human) | | 0.0018 |
Serine/threonine-protein kinase SIK2 | Homo sapiens (human) | | 0.3669 |
Myosin light chain kinase 2, skeletal/cardiac muscle | Homo sapiens (human) | | 0.0147 |
STE20-like serine/threonine-protein kinase | Homo sapiens (human) | | 0.0142 |
Serine/threonine-protein kinase TAO3 | Homo sapiens (human) | | 0.0017 |
Homeodomain-interacting protein kinase 2 | Homo sapiens (human) | | 0.3655 |
Tyrosine-protein kinase Srms | Homo sapiens (human) | | 6.5 |
Homeodomain-interacting protein kinase 3 | Homo sapiens (human) | | 0.456 |
Serine/threonine-protein kinase PLK3 | Homo sapiens (human) | | 0.203 |
Inactive tyrosine-protein kinase PEAK1 | Homo sapiens (human) | | 0.0025 |
Dual specificity protein kinase CLK4 | Homo sapiens (human) | | 0.0723 |
MAP kinase-interacting serine/threonine-protein kinase 2 | Homo sapiens (human) | | 0.0221 |
Serine/threonine-protein kinase Sgk2 | Homo sapiens (human) | | 0.0159 |
Casein kinase I isoform gamma-1 | Homo sapiens (human) | | 5.3367 |
NADPH oxidase 4 | Homo sapiens (human) | | 0.0708 |
Serine/threonine-protein kinase PAK 6 | Homo sapiens (human) | | 0.0327 |
SNF-related serine/threonine-protein kinase | Homo sapiens (human) | | 0.0059 |
Serine/threonine-protein kinase LATS2 | Homo sapiens (human) | | 0.0062 |
Interleukin-1 receptor-associated kinase 4 | Homo sapiens (human) | | 0.0122 |
Serine/threonine-protein kinase 32B | Homo sapiens (human) | | 0.0375 |
Cyclin-dependent kinase 12 | Homo sapiens (human) | | 0.053 |
Serine/threonine-protein kinase PLK2 | Homo sapiens (human) | | 0.546 |
Serine/threonine-protein kinase MARK1 | Homo sapiens (human) | | 0.0003 |
Serine/threonine-protein kinase pim-2 | Homo sapiens (human) | | 0.0813 |
Serine/threonine-protein kinase PAK 5 | Homo sapiens (human) | | 0.0039 |
Serine/threonine-protein kinase 26 | Homo sapiens (human) | | 0.0124 |
Serine/threonine-protein kinase NLK | Homo sapiens (human) | | 0.0666 |
Ribosomal protein S6 kinase beta-2 | Homo sapiens (human) | | 0.0015 |
Protein DBF4 homolog A | Homo sapiens (human) | | 0.0549 |
Serine/threonine-protein kinase 17A | Homo sapiens (human) | | 0.0386 |
STE20/SPS1-related proline-alanine-rich protein kinase | Homo sapiens (human) | | 0.0158 |
Ephrin type-A receptor 6 | Homo sapiens (human) | | 0.0161 |
Serine/threonine-protein kinase TBK1 | Homo sapiens (human) | | 0.003 |
Death-associated protein kinase 2 | Homo sapiens (human) | | 0.0064 |
Ribosomal protein S6 kinase alpha-6 | Homo sapiens (human) | | 0.0001 |
TRAF2 and NCK-interacting protein kinase | Homo sapiens (human) | | 0.0103 |
Serine/threonine-protein kinase tousled-like 1 | Homo sapiens (human) | | 0.0295 |
Serine/threonine-protein kinase TAO2 | Homo sapiens (human) | | 0.0076 |
ALK tyrosine kinase receptor | Homo sapiens (human) | | 0.0044 |
SRSF protein kinase 3 | Homo sapiens (human) | | 1.77 |
Serine/threonine-protein kinase ICK | Homo sapiens (human) | | 0.0443 |
Aurora kinase C | Homo sapiens (human) | | 0.0022 |
Calcium/calmodulin-dependent protein kinase type II subunit alpha | Homo sapiens (human) | | 0.0024 |
Protein kinase C theta type | Rattus norvegicus (Norway rat) | | 0.274 |
RAC-gamma serine/threonine-protein kinase | Homo sapiens (human) | | 0.3701 |
Serine/threonine-protein kinase 38-like | Homo sapiens (human) | | 0.0012 |
Serine/threonine-protein kinase SIK3 | Homo sapiens (human) | | 0.1541 |
Mitogen-activated protein kinase kinase kinase 2 | Homo sapiens (human) | | 0.0335 |
Serine/threonine-protein kinase WNK2 | Homo sapiens (human) | | 1.455 |
Dual specificity tyrosine-phosphorylation-regulated kinase 1B | Homo sapiens (human) | | 0.0017 |
5'-AMP-activated protein kinase subunit beta-1 | Homo sapiens (human) | | 1.1354 |
Mitogen-activated protein kinase kinase kinase kinase 5 | Homo sapiens (human) | | 0.0002 |
Serine/threonine-protein kinase MRCK beta | Homo sapiens (human) | | 0.0027 |
Serine/threonine-protein kinase 24 | Homo sapiens (human) | | 0.0065 |
Casein kinase I isoform gamma-3 | Homo sapiens (human) | | 2.675 |
Chain A, Ribosomal protein S6 kinase alpha-1 | Homo sapiens (human) | | 0.0003 |
Chain X, Tyrosine-protein kinase Lyn | Homo sapiens (human) | | 0.0013 |
Authors | Studies |
Atteridge, CE; Azimioara, MD; Benedetti, MG; Biggs, WH; Carter, TA; Ciceri, P; Edeen, PT; Fabian, MA; Floyd, M; Ford, JM; Galvin, M; Gerlach, JL; Grotzfeld, RM; Herrgard, S; Insko, DE; Insko, MA; Lai, AG; Lélias, JM; Lockhart, DJ; Mehta, SA; Milanov, ZV; Patel, HK; Treiber, DK; Velasco, AM; Wodicka, LM; Zarrinkar, PP | 1 |
Bullock, AN; Fedorov, O; Knapp, S; Marsden, B; Müller, S; Pogacic, V; Rellos, P; Schwaller, J; Sundström, M | 1 |
Atteridge, CE; Campbell, BT; Chan, KW; Ciceri, P; Davis, MI; Edeen, PT; Faraoni, R; Floyd, M; Gallant, P; Herrgard, S; Hunt, JP; Karaman, MW; Lockhart, DJ; Milanov, ZV; Morrison, MJ; Pallares, G; Patel, HK; Pritchard, S; Treiber, DK; Wodicka, LM; Zarrinkar, PP | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Russu, WA; Shallal, HM | 1 |
Chen, X; Chen, Y; Gao, C; Jiang, Y; Li, Y; Liu, H; Luan, X; Tan, C; Zhang, C | 1 |
Ciceri, P; Davis, MI; Herrgard, S; Hocker, M; Hunt, JP; Pallares, G; Treiber, DK; Wodicka, LM; Zarrinkar, PP | 1 |
Al-Mazaideh, GM; Erdmann, F; Göllner, C; Rohe, A; Schmidt, M; Sippl, W; Wichapong, K | 1 |
Abouzid, KA; Farag, NA; Mowafy, S | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Abou El Ella, DA; Aly, RM; El-Motwally, AM; Ibrahim, DA | 1 |
Bocci, G; Cosconati, S; D'Ocon, P; Da Settimo, F; Dalla Via, L; Fioravanti, A; Fornaciari, G; García-Argáez, AN; Gia, O; La Motta, C; Marini, AM; Novellino, E; Orlandi, P; Salerno, S; Sartini, S; Simorini, F; Taliani, S | 1 |
Abouzid, KAM; Esmat, A; Hossam, M; Ismail, NSM; Lasheen, DS; Mansour, AM; Singab, ANB | 1 |
Hou, W; Ma, Y; Ren, Y; Sun, H; Yan, B; Zhang, Z | 1 |
Abou-Zeid, LA; Ashour, HF; El-Sayed, MA; Selim, KB | 1 |
El-Subbagh, HI; Ghaly, MA; Maarouf, AR; Sabry, MA | 1 |
Marais, R; Niculescu-Duvaz, D; Springer, C; Whittaker, S | 1 |
Boggon, TJ; Eck, MJ; Greulich, H; Li, Y; Meyerson, M; Woo, MS; Yun, CH | 1 |
Hsu, CP; Hsu, PY; Lin, JJ; Wu, YL | 1 |
Ding, X; Li, Y; Mao, W; Meng, X; Tang, H; Wang, X; Xie, S; Yang, H | 1 |
Article | Year |
A small molecule-kinase interaction map for clinical kinase inhibitors.Nature biotechnology, 2005, Volume: 23, Issue:3
Topics: Benzamides; Drug Design; Escherichia coli; Escherichia coli Proteins; Imatinib Mesylate; Microchemistry; Pharmaceutical Preparations; Piperazines; Protein Binding; Protein Interaction Mapping; Protein Kinase Inhibitors; Pyrimidines | 2005 |
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.Proceedings of the National Academy of Sciences of the United States of America, 2007, Dec-18, Volume: 104, Issue:51
Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases | 2007 |
A quantitative analysis of kinase inhibitor selectivity.Nature biotechnology, 2008, Volume: 26, Issue:1
Topics: Binding Sites; Enzyme Activation; Humans; Phosphotransferases; Protein Binding; Protein Interaction Mapping; Protein Kinase Inhibitors; Proteome; Quantitative Structure-Activity Relationship | 2008 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.Toxicological sciences : an official journal of the Society of Toxicology, 2010, Volume: 118, Issue:2
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Discovery, synthesis, and investigation of the antitumor activity of novel piperazinylpyrimidine derivatives.European journal of medicinal chemistry, 2011, Volume: 46, Issue:6
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Molecular Structure; Piperazines; Protein Kinase Inhibitors; Protein Kinases; Pyrimidines; Stereoisomerism; Structure-Activity Relationship | 2011 |
Discovery of benzimidazole derivatives as novel multi-target EGFR, VEGFR-2 and PDGFR kinase inhibitors.Bioorganic & medicinal chemistry, 2011, Aug-01, Volume: 19, Issue:15
Topics: Antineoplastic Agents; Benzimidazoles; Cell Proliferation; Drug Discovery; ErbB Receptors; Hep G2 Cells; Humans; Models, Molecular; Neoplasms; Protein Kinase Inhibitors; Receptors, Platelet-Derived Growth Factor; Structure-Activity Relationship; Vascular Endothelial Growth Factor Receptor-2 | 2011 |
Comprehensive analysis of kinase inhibitor selectivity.Nature biotechnology, 2011, Oct-30, Volume: 29, Issue:11
Topics: Catalysis; Drug Design; Enzyme Stability; High-Throughput Screening Assays; Humans; Protein Binding; Protein Kinase Inhibitors; Protein Kinases; Proteomics; Signal Transduction; Substrate Specificity | 2011 |
Evaluation of potential Myt1 kinase inhibitors by TR-FRET based binding assay.European journal of medicinal chemistry, 2013, Volume: 61Topics: Dose-Response Relationship, Drug; Fluorescence Resonance Energy Transfer; Glycolipids; Humans; Membrane Proteins; Models, Molecular; Molecular Structure; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Structure-Activity Relationship | 2013 |
Design, synthesis and in vitro anti-proliferative activity of 4,6-quinazolinediamines as potent EGFR-TK inhibitors.European journal of medicinal chemistry, 2013, Volume: 61Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Crystallography, X-Ray; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; ErbB Receptors; Humans; Molecular Docking Simulation; Molecular Structure; Protein Kinase Inhibitors; Structure-Activity Relationship | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Molecular design and synthesis of certain new quinoline derivatives having potential anticancer activity.European journal of medicinal chemistry, 2015, Sep-18, Volume: 102Topics: Antineoplastic Agents; Cell Proliferation; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; ErbB Receptors; Humans; MCF-7 Cells; Molecular Structure; Protein Kinase Inhibitors; Quinolines; Structure-Activity Relationship | 2015 |
Investigation of new 2-aryl substituted Benzothiopyrano[4,3-d]pyrimidines as kinase inhibitors targeting vascular endothelial growth factor receptor 2.European journal of medicinal chemistry, 2015, Oct-20, Volume: 103Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Human Umbilical Vein Endothelial Cells; Humans; Models, Molecular; Molecular Structure; Protein Kinase Inhibitors; Pyrans; Pyrimidines; Structure-Activity Relationship; Vascular Endothelial Growth Factor Receptor-2 | 2015 |
Discovery of anilino-furo[2,3-d]pyrimidine derivatives as dual inhibitors of EGFR/HER2 tyrosine kinase and their anticancer activity.European journal of medicinal chemistry, 2018, Jan-20, Volume: 144Topics: Aniline Compounds; Animals; Antineoplastic Agents; Cell Proliferation; Dose-Response Relationship, Drug; Drug Discovery; Drug Screening Assays, Antitumor; ErbB Receptors; Female; Humans; Mice; Molecular Structure; Neoplasms, Experimental; Protein Kinase Inhibitors; Pyrimidines; Structure-Activity Relationship; Tumor Cells, Cultured | 2018 |
Novel quinazoline derivatives bearing various 6-benzamide moieties as highly selective and potent EGFR inhibitors.Bioorganic & medicinal chemistry, 2018, 05-01, Volume: 26, Issue:8
Topics: Antineoplastic Agents; Benzamides; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; ErbB Receptors; Humans; Molecular Structure; Protein Kinase Inhibitors; Quinazolines; Structure-Activity Relationship; Tumor Cells, Cultured | 2018 |
1,2,3-Triazole-Chalcone hybrids: Synthesis, in vitro cytotoxic activity and mechanistic investigation of apoptosis induction in multiple myeloma RPMI-8226.European journal of medicinal chemistry, 2020, Mar-01, Volume: 189Topics: Antineoplastic Agents; Apoptosis; Caspase 3; Cell Cycle; Cell Proliferation; Chalcones; Humans; Molecular Structure; Multiple Myeloma; Proto-Oncogene Proteins c-bcl-2; Structure-Activity Relationship; Triazoles; Tumor Cells, Cultured | 2020 |
New thiazole-based derivatives as EGFR/HER2 and DHFR inhibitors: Synthesis, molecular modeling simulations and anticancer activity.European journal of medicinal chemistry, 2022, Nov-05, Volume: 241Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; ErbB Receptors; Folic Acid Antagonists; Molecular Docking Simulation; Molecular Structure; Protein Kinase Inhibitors; Structure-Activity Relationship; Thiazoles | 2022 |
The EGF receptor Hokey-Cokey.Cancer cell, 2007, Volume: 11, Issue:3
Topics: Antineoplastic Agents; Enzyme Activation; ErbB Receptors; Gefitinib; Humans; Lapatinib; Models, Molecular; Mutation; Protein Conformation; Protein Structure, Tertiary; Purines; Quinazolines; Staurosporine | 2007 |
Structures of lung cancer-derived EGFR mutants and inhibitor complexes: mechanism of activation and insights into differential inhibitor sensitivity.Cancer cell, 2007, Volume: 11, Issue:3
Topics: Antineoplastic Agents; Binding Sites; Carcinoma, Non-Small-Cell Lung; Crystallography, X-Ray; Enzyme Activation; ErbB Receptors; Gefitinib; Humans; Lapatinib; Lung Neoplasms; Models, Molecular; Mutation; Protein Conformation; Protein Structure, Tertiary; Purines; Quinazolines; Staurosporine | 2007 |
Detecting the effect of targeted anti-cancer medicines on single cancer cells using a poly-silicon wire ion sensor integrated with a confined sensitive window.Biomedical microdevices, 2012, Volume: 14, Issue:5
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Antineoplastic Agents; Apoptosis; Biosensing Techniques; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Drug Delivery Systems; Gefitinib; Humans; Ions; Lung Neoplasms; Propylamines; Quinazolines; Silanes; Silicon; Single-Cell Analysis; Staurosporine | 2012 |
Drug response to HER2 gatekeeper T798M mutation in HER2-positive breast cancer.Amino acids, 2016, Volume: 48, Issue:2
Topics: Antineoplastic Agents; Breast Neoplasms; Bridged Bicyclo Compounds, Heterocyclic; Drug Resistance, Neoplasm; ErbB Receptors; Erlotinib Hydrochloride; Female; Gefitinib; Humans; Hydroxybutyrates; Lapatinib; Molecular Dynamics Simulation; Mutation; Protein Kinase Inhibitors; Purines; Quinazolines; Receptor, ErbB-2; Staurosporine | 2016 |